Thursday, June 11

Browsing: MDSMPN

Treatments

Fedratinib is “Uniquely Positioned” in MDS/MPN Treatment

By NewsCancerJune 3, 20260

Data from a phase 2 study (NCT05177211) presented at the 2026 American Society of Clinical Oncology Annual Meeting (ASCO) showed…

Diagnosis

By NewsCancerFebruary 27, 20260

In a conversation with CancerNetwork® at the 2026 Tandem Meetings, Fernando Duarte, MD, PhD, spoke about key findings from a…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.